tirzepatide landmark trial for masld Obesity Treatment and Diabetes Prevention Incretin-based therapies in MASLD/MASH: from

Adjusting injection timing relative to the menstrual cycle is a personalized strategy worth experimenting with

Phase-3 MARITIME Program: Two pivotal 72-week studies, MARITIME-1 and MARITIME-2, are underway to confirm efficacy and safety in broader populations

When used regularly in a soap formulation, it helps reduce the appearance of dark spots and promotes a more even skin tone

Per Vaca-Flores, youll be good to go by pairing both at the same meal, though you can hack your routine to supercharge results even further

You need to manage nausea carefully

A qualified healthcare provider should evaluate whether dose adjustment, timing changes, or alternative formulations may improve tolerability